How Nobel-winning chemists used and directed evolution

October 3, 2018
US scientists Frances Arnold and George Smith and British researcher Gregory Winter have won the 2018 Nobel Chemistry Prize

Three scientists shared the 2018 Nobel Chemistry Prize on Wednesday for their work in harnessing the power of evolution, which led to a range of breakthroughs including better biofuels and more targeted drugs.

Here is a brief explanation of their discoveries and how they have been applied:

New enzymes

Frances Arnold of the US was awarded for using the principles of evolution to develop new enzymes, which are the basic chemical tools of life.

At first she tried to force such changes using more traditional methods, but her breakthrough came when she allowed evolutionary forces such as selection and even chance to govern the development of enzymes, while still subtly guiding them.

It was the first step toward a revolution in the field, with the slight but fundamental changes leading to more environmentally friendly chemical substances, new pharmaceuticals, and more renewable fuels, according to the Royal Swedish Academy of Sciences.

Phage antibodies

The principles behind evolution were also used by the other Nobel winners, George Smith of the US and Britain's Gregory Winter, who focused on tiny viruses that infect bacteria called bacteriophages—or phages for short.

Using this invading element, George Smith invented an "elegant" method called display in which these invading phages introduce —which function like "targeted missiles", the Academy said.

Gregory Winter then applied directed to develop the world's first pharmaceutical entirely based on a human antibody.

This has since led to a wide range of different drugs that can target certain tumour cells, arthritis, the toxin that causes anthrax, help slow down lupus and even in some cases cure metastatic cancer.

Many more such antibodies are currently undergoing clinical trials, including some to combat Alzheimer's disease, the Academy said.

Alan Boyd, president of Britain's Faculty of Pharmaceutical Medicine, hailed the award.

"The use of antibodies has resulted in a paradigm shift in the way that we now treat so many diseases which has brought significant benefits to patients across the world and will continue to do so for years to come," he said.

Explore further: 'Darwin in a test tube': Trio wins Nobel for harnessing evolution

Related Stories

Predicting relapses in patients with autoimmune vascular disease

May 23, 2018

Patients with an autoimmune disorder called antineutrophil cytoplasmic antibody-associated vasculitis produce antibodies that damage blood vessels in the body. In some cases, patients' antibodies target a protein called myeloperoxidase. ...

Recommended for you

Field-responsive mechanical metamaterials (FRMMs)

December 11, 2018

In a recent study published in Science Advances, materials scientists Julie A. Jackson and colleagues presented a new class of materials architecture called field-responsive mechanical metamaterials (FRMM). The FRMMs exhibit ...

CRISPR method for conditional gene regulation

December 11, 2018

A team of engineers at the University of Delaware has developed a method to use CRISPR/Cas9 technology to set off a cascade of activities in cells, a phenomenon known as conditional gene regulation. Their method, described ...

Researchers develop smartphone-based ovulation test

December 11, 2018

Investigators from Brigham and Women's Hospital are developing an automated, low-cost tool to predict a woman's ovulation and aid in family planning. Capitalizing on advancements in several areas, including microfluidics, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.